Aurobindo Pharma Q1FY25 outcomes: Web revenue jumps 61% to Rs 919 cr | Firm Outcomes
The profitability was sustained by improved gross margins and operational efficiencies: Aurobindo Pharma VCMD | Photograph: ...
Read moreThe profitability was sustained by improved gross margins and operational efficiencies: Aurobindo Pharma VCMD | Photograph: ...
Read moreCopyright © 2022 Real Invest Solutions.
Copyright © 2022 Real Invest Solutions.